Stereotactic body radiation therapy for treatment of primary and metastatic pulmonary malignancies.

Journal Article (Journal Article;Review)

Stereotactic body radiation therapy (SBRT) has become the preferred treatment approach for patients with stage I non-small cell lung cancer who are medically inoperable or refuse surgery. SBRT consists of 3 to 5 radiation treatments delivered over a 10- to 14-day period. Local control is achieved in approximately 90% of patients, and the risk of toxicity is relatively low. Ongoing studies are examining whether SBRT can replace surgery for certain patients, the optimal dose-fractionation scheme, and how best to treat patients having central tumors near the primary tracheobronchial tree.

Full Text

Duke Authors

Cited Authors

  • Kelsey, CR; Salama, JK

Published Date

  • July 2013

Published In

Volume / Issue

  • 22 / 3

Start / End Page

  • 463 - 481

PubMed ID

  • 23622074

Electronic International Standard Serial Number (EISSN)

  • 1558-5042

Digital Object Identifier (DOI)

  • 10.1016/j.soc.2013.02.011

Language

  • eng

Conference Location

  • United States